21 May 2020
As many as 47 coronavirus vaccines are in the works in Russia, Deputy Prime Minister Tatyana Golikova said, addressing the Federation Council (the upper house of parliament) on May 20.
“Detecting the coronavirus infection is an important aspect of these activities. A total of 47 vaccines are in the works on 14 platforms. We do expect that some of them will produce tangible results,” she said.
Golikova added that 3.1 bln rubles ($43 mln) had been allocated from the federal budget for the development of coronavirus testing systems and vaccines.
Director of Russia’s Gamaleya Scientific Research Institute of Epidemiology and Microbiology Alexander Gintsburg said earlier that a coronavirus vaccine could be registered in Russia in August. According to him, pre-clinical trials are expected to last for about another month. These trials are aimed at figuring out vaccine toxicity and reactogenicity, as well as other properties, based on which human trials can be launched.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024